Rose Ophthalmic Industries Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 29-06-2024
- Paid Up Capital ₹ 0.10 M
as on 29-06-2024
- Company Age 26 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.34 Cr
as on 29-06-2024
- Revenue %
(FY 2020)
- Profit -40.05%
(FY 2020)
- Ebitda 50.55%
(FY 2020)
- Net Worth -1.33%
(FY 2020)
- Total Assets -0.11%
(FY 2020)
About Rose Ophthalmic Industries
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹4.34 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Joseph Sebastian and Ponnan Rebello serve as directors at the Company.
- CIN/LLPIN
U33112KL1998PTC012023
- Company No.
012023
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jan 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Rose Ophthalmic Industries?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Joseph Sebastian  | Managing Director | 16-Jan-1998 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ponnan Rebello | Director | 17-Mar-2018 | Current |
Financial Performance of Rose Ophthalmic Industries.
Rose Ophthalmic Industries Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 40.05% decrease in profit. The company's net worth dipped by a decrease of 1.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rose Ophthalmic Industries?
In 2018, Rose Ophthalmic Industries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Rose India Tour Managers Private LimitedActive 20 years 6 months
Joseph Sebastian is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 12 Mar 2011 | ₹1.68 Cr | Satisfied |
State Bank Of India Creation Date: 30 Nov 2005 | ₹1.88 Cr | Satisfied |
The Dhanalakshmi Bank Limited Creation Date: 11 Oct 2001 | ₹3.79 M | Satisfied |
How Many Employees Work at Rose Ophthalmic Industries?
Unlock and access historical data on people associated with Rose Ophthalmic Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rose Ophthalmic Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rose Ophthalmic Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
